Publisher
Springer Nature Singapore
Reference20 articles.
1. Apte AV, Kumar V, Sharma SP, Arya NC, Gangopadhyay AN, Gupta DK, et al. How safe and effective is preoperative intratumoral chemotherapy in advanced inoperable pediatric solid malignancies? J Indian Assoc Pediatr Surg. 2001;6:119–24.
2. Goldberg EP, Hadba AR, Almond BA, Marotta JS. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol. 2002;54:159–80. https://doi.org/10.1211/0022357021778268.
3. Kumar V, Ramaswami N, Pandey A, Shukla RC, Sen MR, Sharma SP, et al. Clinico-immunological response to intratumoral versus intravenous neoadjuvant chemotherapy in advanced pediatric solid malignancies. Indian J Med Paediatr Oncol. 2013;34:80–4. https://doi.org/10.4103/0971-5851.116183.
4. Nelson D, Fisher S, Robinson B. The “Trojan Horse” approach to tumor immunotherapy: targeting the tumor microenvironment. J Immunol Res. 2014;2014:789069. https://doi.org/10.1155/2014/789069.
5. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71–8. https://doi.org/10.1038/nrc1256.